Stay updated on Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial
Sign up to get notified when there's something new on the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page.

Latest updates to the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page
- CheckyesterdayChange DetectedA large number of core terms and sections central to the study record have been deleted, including disease names, treatments, eligibility criteria, location details, and investigators. This reduces the page's clarity and navigability.SummaryDifference17%

- Check8 days agoChange DetectedThe page now displays Revision: v3.3.4 instead of v3.3.3.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedAdded a Locations section with a new site in Seattle, Washington. Washington is now listed as a study location.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page footer revision updated from v3.3.1 to v3.3.2; no other sections of the study details were altered.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page no longer displays the temporary operating status notice regarding funding. Core study information remains unchanged.SummaryDifference0.4%

Stay in the know with updates to Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose effect of HSV-2 therapy on HSV and HIV Clinical Trial page.